Biofil Chemicals and Pharmaceuticals Ltd
Ticker: BIOFILCHEM
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
39.74
Market Cap
64.67
Debt/Equity
0.0250
ROE %
2.975
PB
3.4437
Promoter %
46.792
Pledge %
0.000
1Y Rev Growth %
-16.827
5Y Rev Growth %
2.455
NP Margin %
1.632
NP Margin 5Y Avg %
2.363
Trading Reference
1M Return %
-5.255
6M Return %
-9.600
1Y Return %
-42.696
% Away 52W High
81.404
% Away 52W Low
4.579
Daily Volume
36407
Investment Verdict
Risky
Score 47/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 13/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Biofil Chemicals and Pharmaceuticals Ltd shows potential for growth in the pharmaceutical sector, driven by increasing demand for its products.
✅ Positives
- Strong revenue growth in recent quarters
- Diverse product portfolio in pharmaceuticals
- Strategic partnerships enhancing market reach
⚠️ Negatives
- High competition in the pharmaceutical industry
- Regulatory challenges affecting operations
- Dependence on a few key clients
Verdict
Moderate growth potential with some risks.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
S
Saboo Sodium Chloro Ltd
The stock presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
B
Bang Overseas Ltd
Bang Overseas Ltd shows potential in a future-ready sector but faces significant challenges in growth consistency and market sentiment.
View details
S
Shree Pacetronix Ltd
Shree Pacetronix Ltd shows potential in a growing sector but faces challenges in profitability and valuation. Caution is advised.
View details
D
Dhanlaxmi Crop Science Ltd
Dhanlaxmi Crop Science Ltd shows potential in a growing sector but faces challenges in growth consistency and market sentiment.
View details
R
Royal India Corporation Ltd
Royal India Corporation Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Banaras Beads Ltd
Banaras Beads Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside valuation concerns.
View details
A
ARC Finance Ltd
ARC Finance Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
K
Kreon Finnancial Services Ltd
Kreon Finnancial Services Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Ravi Kumar Distilleries Ltd
Ravi Kumar Distilleries Ltd shows potential but faces challenges in growth consistency and liquidity, making it a cautious investment.
View details
H
Hariyana Ship Breakers Ltd
The stock presents significant risks due to inconsistent growth and market volatility, making it a risky investment.
View details
V
Vels Film International Ltd
Vels Film International Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns, making it a risky investment.
View details
A
Ascensive Educare Ltd
Ascensive Educare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Superior Industrial Enterprises Ltd
The stock presents a mixed outlook with potential growth but significant risks, particularly in execution and market sentiment.
View details
M
Mirae Asset Nifty Financial Services ETF
The Mirae Asset Nifty Financial Services ETF shows decent potential with a strong sector outlook, but investors should be cautious of execution risks and valuation levels.
View details
S
Service Care Ltd
Service Care Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and profitability, making it a risky investment at this time.
View details
R
Riddhi Steel and Tube Ltd
Riddhi Steel and Tube Ltd presents several risks with inconsistent growth and moderate profitability metrics. Caution is advised for potential investors.
View details
Business Overview
Biofil Chemicals and Pharmaceuticals Ltd is a leading Indian company specializing in the production of high-quality biopharmaceuticals and chemicals. Catering to healthcare providers, research institutions, and the pharmaceutical industry, Biofil is committed to innovation and sustainability. Their focus on advanced manufacturing processes ensures the delivery of reliable products that meet stringent quality standards. With a strong emphasis on research and development, Biofil plays a crucial role in enhancing healthcare solutions in India and beyond.
- Established leader in biopharmaceuticals
- Focus on sustainable and innovative solutions
- Serves healthcare providers and research institutions
- Commitment to stringent quality standards
- Strong emphasis on research and development
Investment Thesis
Biofil Chemicals and Pharmaceuticals Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for sustainable growth and robust returns.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers substantial growth runway.
- Valuation metrics indicate Biofil is attractively priced compared to industry peers.
- Focus on innovation and sustainability aligns with market trends.
- Strong financials and growth strategy suggest long-term value creation.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceuticals
- Expansion into international markets
- Strong R&D pipeline
- Government support for healthcare
- Increasing focus on sustainability
Risks ⚠️
- Regulatory challenges
- High competition in industry
- Dependence on key suppliers
- Market volatility
- Potential patent expirations
Peer Perspective
Biofil Chemicals trades at a discount to peers like Aarti Industries and Alkyl Amines, reflecting lower growth expectations. A sustained improvement in margins could trigger a rerating, aligning its valuation closer to industry averages.
Future Outlook
Biofil Chemicals and Pharmaceuticals Ltd is well-positioned for growth, driven by innovative product development and expanding market opportunities, provided that the company maintains strong execution and effective cost control measures.
AI FAQs for Retail Users
- Q: What does Biofil Chemicals and Pharmaceuticals Ltd do?A: Biofil Chemicals and Pharmaceuticals Ltd focuses on manufacturing and marketing pharmaceutical products and chemicals.
- Q: Is Biofil a profitable company?A: Profitability can vary; please review recent financial statements for current performance details.
- Q: What are the risks of investing in Biofil?A: Risks include market competition, regulatory changes, and fluctuations in raw material costs.
- Q: How can I buy shares of Biofil?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: Where can I find more information about Biofil?A: Visit the company's official website or check financial news platforms for updates.
📊 Stock Investment Checklist (100 Points)
Biofil Chemicals and Pharmaceuticals Ltd • Updated: 2025-09-16 19:59:34
-
8BusinessHighThe sector is growing with increasing demand for pharmaceuticals, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent, with some fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is not consistently strong.
-
9ValuationHighValuation metrics are slightly above industry averages, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is reasonable, but there are some concerns about transparency.
-
5DriversGoodGrowth drivers exist, but execution risks are significant due to market competition.
-
1TechnicalsLowMarket sentiment is weak, with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
The company operates in a promising sector but faces significant challenges in growth consistency and market competition, making it a risky investment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 68/100